Rahul D. Ballal - 07 Nov 2024 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Reporting relationship: Director
Issuer ticker: AGIO
Reported as of: 07 Nov 2024
Net transaction value: -$597,347
SEC form: 4
Accepted by SEC: 12 Nov 2024, 16:09:38 UTC
Prior SEC filing: 10 Oct 2024
Next SEC filing: 10 Feb 2025
Source filing: View source filing
Reporting owner signature: /s/ William Cook, as attorney-in-fact for Rahul Ballal

Key filing fact

Rahul D. Ballal filed Form 4 for AGIOS PHARMACEUTICALS, INC. (AGIO) on 12 Nov 2024.

Key facts

This page summarizes Rahul D. Ballal's Form 4 filing for AGIOS PHARMACEUTICALS, INC. (AGIO).
9 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 12 Nov 2024, 16:09.

Change

Previous filing in this sequence was filed on 10 Oct 2024.
Current net transaction value: -$597,347.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AGIO transaction

Common stock

Options Exercise

Transaction value: $259,900
Shares: +10,000
Change %: +125%
Price: $25.99
Shares after: 17,992
Date: 07 Nov 2024
Ownership: Direct
Footnotes: F1

AGIO transaction

Common stock

Sale

Transaction value: $433,598
Shares: -8,132
Change %: -45%
Price: $53.32
Shares after: 9,860
Date: 07 Nov 2024
Ownership: Direct
Footnotes: F1, F2

AGIO transaction

Common stock

Sale

Transaction value: $101,638
Shares: -1,868
Change %: -19%
Price: $54.41
Shares after: 7,992
Date: 07 Nov 2024
Ownership: Direct
Footnotes: F1, F3

AGIO transaction

Common stock

Options Exercise

Transaction value: $259,900
Shares: +10,000
Change %: +125%
Price: $25.99
Shares after: 17,992
Date: 08 Nov 2024
Ownership: Direct
Footnotes: F1

AGIO transaction

Common stock

Sale

Transaction value: $204,404
Shares: -3,571
Change %: -20%
Price: $57.24
Shares after: 14,421
Date: 08 Nov 2024
Ownership: Direct
Footnotes: F1, F4

AGIO transaction

Common stock

Sale

Transaction value: $288,692
Shares: -4,929
Change %: -34%
Price: $58.57
Shares after: 9,492
Date: 08 Nov 2024
Ownership: Direct
Footnotes: F1, F5

AGIO transaction

Common stock

Sale

Transaction value: $88,815
Shares: -1,500
Change %: -16%
Price: $59.21
Shares after: 7,992
Date: 08 Nov 2024
Ownership: Direct
Footnotes: F1, F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AGIO transaction Derivative

Stock option (right to buy)

Options Exercise

Transaction value: $0
Shares: -10,000
Change %: -26%
Price: $0.000000
Shares after: 27,947
Date: 07 Nov 2024
Ownership: Direct
Underlying class: Common stock
Underlying amount: 10,000
Exercise price: $25.99
Footnotes: F1, F7

AGIO transaction Derivative

Stock option (right to buy)

Options Exercise

Transaction value: $0
Shares: -10,000
Change %: -36%
Price: $0.000000
Shares after: 17,947
Date: 08 Nov 2024
Ownership: Direct
Underlying class: Common stock
Underlying amount: 10,000
Exercise price: $25.99
Footnotes: F1, F7

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 7 footnotes

Footnote F1

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Footnote F2

The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $53.00 to $53.84. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Footnote F3

The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $54.02 to $54.60. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Footnote F4

The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $57.00 to $58.00. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Footnote F5

The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $58.00 to $58.99. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Footnote F6

The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $59.01 to $59.37. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Footnote F7

This option was granted on August 11, 2022. The shares underlying this option vest as to 25% of the underlying shares on August 11, 2023, with the remaining 75% vesting in 36 equal monthly installments thereafter.